Glenmark starts clinical trials for potential Covid-19 drug in India

Glenmark said clinical trials of the Covid-19 drug have begun and more than 10 leading government and private hospitals in India are being enrolled for the study. It estimates the study completion by July or August this year.

from Hindustan Times - topnews https://ift.tt/2WlYdd6